Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

KZIAKZIA
5 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in KAZIA THERAPEUTICS LTD

Yes. RhumbLine Advisers holds 1,296 shares of KZIA (Kazia Therapeutics), worth $18,245, as of its Q2 2026 13F filing. It reduced the position by 106 shares (-7.6%) from Q1 2026. RhumbLine Advisers has held KZIA since Q2 2025, across 5 quarterly 13F filings.

Current Value

$18,245

Current Shares

1,296

Total Value Change

+$14,582

Total Shares Change

+705

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1,296
-7.6%
$18,2450.0%$14.08
0
2026-Q1
Decreased
1,402
-10.4%
$10,4280.0%$7.44
0
2025-Q4
Increased
1,565
+164.8%
$10,7790.0%$6.89
19
2025-Q3
Unchanged
591
0.0%
$4,3240.0%$7.21
0
2025-Q2
New
591
-
$3,6630.0%$6.27
21

Other major holders of KZIA: Alyeska Investment Group, L.P., Point72 Asset Management, L.P., Ensign Peak Advisors, Inc, BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used